Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2023

Aug 10, 2023

33899_dirs_2023-08-10_60b388b0-e96d-4696-bd8c-59b78513a0a8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-08-08

Reporting Person: Hoer Michael A. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-08 Common Stock P 37.644 $89.42 Acquired 8325.709 Direct

Footnotes

F1: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.